Info for medical societies

Navigation

Shopping cart

Shopping cart is empty.

View cart

American Association of Poison Control Centers Guidelines

Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Acetaminophen poisoningNote: This guideline applies to ingestion of acetaminophen alone. Co-ingestion of additional substances could require different referral and management recommendation depending on the combined toxicities of the substances.
Published Date: 2005
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

1

FDA Warning

Atypical antipsychotic medication poisoning: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Atypical antipsychotic medication poisoningNote:This guideline applies to ingestion of atypical antipsychotic medications alone. Co-ingestion of additional substances could require different referral and management recommendations depending on the combined toxicities of the substances.This guideline does not provide guidance on exposures to typical antipsychotics such as phenothiazines and butyrophenones which have different pharmacological effects and toxicity profiles.This guideline does not address management of patients who experience chronic toxicity or adverse effects from chronic atypical antipsychotic medication use such as their endocrine effects and clozapine-associated agranulocytosis.
Published Date: 2007 Aug 6
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning

Beta-blocker ingestion: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Beta-blocker poisoningNote: This guideline applies to ingestion of beta-blockers alone. Co-ingestion of additional substances could require different referral and management recommendation depending on the combined toxicities of the substances.
Published Date: 2005 Mar 30
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning

Calcium channel blocker ingestion: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Calcium channel blocker (CCB) poisoningNotes:This guideline focuses on the ingestion of more than a single therapeutic dose (overdose). Articles that reported adverse effects related to usual therapeutic doses and with therapeutic intent were not included in the review.This guideline applies to ingestion of CCBs alone. Co-ingestion of additional substances could require different referral and management recommendation depending on the combined toxicities of the substances.
Published Date: 2005
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

1

FDA Warning

Camphor poisoning: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Camphor poisoningNote: This guideline applies to exposure to camphor alone. Co-ingestion of additional substances such as in commercial products of camphor combined with other ingredients could require different referral and management recommendations depending on the combined toxicities of the substances
Published Date: 2006 Feb 16
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

1

FDA Warning

Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Dextromethorphan poisoningNote:This guideline applies to the ingestion of dextromethorphan alone. Co-ingestion of additional substances could require different referral and management recommendations depending on the combined toxicities of the substances.This review focuses on the ingestion of more than a single therapeutic dose and the effects of overdoses. Although therapeutic doses of dextromethorphan can cause adverse effects in adults and children some idiosyncratic and some dose-dependent these cases are not considered here.
Published Date: 2007 May 24
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning

Diphenhydramine and dimenhydrinate poisoning: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Diphenhydramine and dimenhydrinate poisoningNotes:This guideline applies to unintentional exposures or exposures that are the results of errors following therapeutic use. Exposures resulting from intentional abuse or self-harm will all require referral to an emergency department for evaluation.This guideline applies to ingestion or dermal application of diphenhydramine or the ingestion of dimenhydrinate alone. Co-ingestion of additional substances could require different referral and management recommendations depending on the combined toxicities of the substances.
Published Date: 2005 Aug 26
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning

Elemental mercury exposure: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Elemental mercury exposureNote:This guideline addresses small spills and human exposures to elemental mercury. Exposures to organic mercury compounds (e.g. methylmercury) or inorganic mercuric salts (e.g. mercuric chloride) are not included.In addition this guideline does not address chronic occupational exposure or large industrial releases of elemental mercury. It focuses primarily on small spills (typically less than 5 mL) that occur in a home or public area. It does not address aspiration or intravenous exposure to elemental mercury.
Published Date: 2007 Apr 9
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning

Ethylene glycol exposure an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Ethylene glycol poisoningNote: This guideline applies to exposure of ethylene glycol alone. Exposure to additional substances could require different referral and management recommendation depending on the combined toxicities of the substances
Published Date: 2005 May 3
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning

Guideline on the use of ipecac syrup in the out-of-hospital management of ingested poisons

Category:
Conditions: Ingested poisons
Published Date: 2004
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning

Iron ingestion: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Iron poisoningNote:This guideline applies to ingestion of iron alone. Co-ingestion of additional substances could require different referral and management recommendation depending on the combined toxicities of the substances.The guideline considers acute exposure to iron only which is defined as a single exposure or multiple exposures occurring within a period of 8 hours.??? The guideline does not deal with chronic oral exposures or parenteral iron exposures.
Published Date: 2005 May 3
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

1

FDA Warning

Long-acting anticoagulant rodenticide poisoning: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Long-acting anticoagulant rodenticide (LAARs) poisoningNote: This guideline applies to exposure to LAARs alone. Exposure to additional substances could require different referral and management recommendations depending on the individual or combined toxicities of the substances.
Published Date: 2006 Apr 19
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning

Methylphenidate poisoning an evidencebased consensus guideline for outofhospital management

Category: Emergency Medicine, Family Practice, Internal Medicine, Pediatrics
Conditions: Methylphenidate poisoningNote:This guideline applies to ingestion of methylphenidate alone. Ingestion of additional substances could require different referral and management recommendations depending on the combined toxicities of the substances.This review focuses on the ingestion of more than a single therapeutic dose and the effects of an overdose. Although therapeutic use of methylphenidate can sometimes cause adverse effects in adults and children—some idiosyncratic and some dose-dependent—these cases are not considered.
Published Date: 2007 Feb 9
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

TRUE

FDA Warning

Salicylate poisoning: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Salicylate poisoningThis guideline applies to exposure to the specified salicylates alone. Exposure to additional substances could require different referral and management recommendations depending on the combined toxicities of the substances.This review focuses on the ingestion of more than a single therapeutic dose and the effects of an overdose. Although therapeutic doses of salicylate can sometimes cause adverse effects in adults and children—some idiosyncratic and some dose-dependent—these cases are not considered.The management of Reye's syndrome associated with aspirin use in children is beyond the scope of this guideline.This guideline does not address bismuth toxicity resulting from bismuth subsalicylate ingestion.
Published Date: 2006 May 23
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning

Selective serotonin reuptake inhibitor poisoning: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Selective serotonin reuptake inhibitor (SSRI) poisoningNotes:The following pure SSRIs are subjects of this guideline: citalopram (Celexa) escitalopram (Lexapro) fluoxetine (Prozac) fluvoxamine (Luvox) paroxetine (Paxil) and sertraline (Zoloft).A number of other agents are also available that have among their pharmacologic properties the ability to inhibit serotonin reuptake. These include bupropion duloxetine mirtazapine and venlafaxine. Given their pharmacologic complexity and distinction from SSRIs they are not included in this guideline.The guideline applies to ingestion of immediate-release forms of SSRIs; alternative-release mechanisms particularly sustained-release preparations are not considered.Co-ingestion of additional substances might but does not necessarily require different referral and management recommendations depending on the nature of the coingestant(s) and the combined toxicities of the substances.
Published Date: 2006 Oct 30
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

1

FDA Warning

Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Tricyclic antidepressant poisoningNote: This guideline does not provide guidance on exposures to some antidepressants such as maprotiline amoxapine and loxapine which are heterocyclic compounds with somewhat different adverse effect profiles. Dothiepin dibenzepin melipramine prothiaden (dosulepin) and other antidepressants not currently available in the U.S. are not included in this guideline.This guideline applies to ingestion of tricyclic antidepressants alone. Co-ingestion of additional substances could require different referral and management recommendations depending on their combined toxicities.
Published Date: 2006 Jul 19
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning

Valproic acid poisoning: an evidence-based consensus guideline for out-of-hospital management

Category:
Conditions: Valproic acid poisoningNote:This guideline applies to the acute ingestion and acute-on-chronic ingestion of immediate-release and extended-release dosage forms of valproic acid divalproex and valproate sodium alone. Co-ingestion of additional substances could require different referral and management recommendations depending on the combined toxicities of the substances.This review focuses on the ingestion of more than a single therapeutic dose and the effects of an overdose. Although therapeutic doses of valproic acid can cause adverse effects in adults and children some idiosyncratic and some dose-dependent these cases are not considered.
Published Date: 2006 Dec 22
Published by: American Association of Poison Control Centers

Pocket Card

PDA Version

0

FDA Warning